Genetic variation in chromosomal translocation breakpoint and immune function genes and risk of non-Hodgkin lymphoma

Cancer Causes and Control

Volumn 21, Issue 5, 2010, Pages 759-769

  Fernberg, Pia ^a   Chang, Ellen T ^b,e   Duvefelt, Kristina ^a   Hjalgrim, Henrik ^c   Eloranta, Sandra ^a   Sørensen, Karina Meden ^c   Porwit, Anna ^a   Humphreys, Keith ^a   Melbye, Mads ^c   Smedby, Karin Ekström ^d  

^a KAROLINSKA INSTITUTE   (Sweden)

^b NORTHERN CALIFORNIA CANCER CENTER   (United States)

^c STATENS SERUM INSTITUT   (Denmark)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^e STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Autoimmunity; Genetic polymorphisms; Interleukin 10; Non Hodgkin lymphoma; Tumor necrosis factor

Indexed keywords

INTERLEUKIN 10; MYC PROTEIN; PROTEIN BCL 2; PROTEIN CCND1; TUMOR NECROSIS FACTOR; TUMOR PROTEIN; UNCLASSIFIED DRUG; CCND1 PROTEIN, HUMAN; CYCLIN D1; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; AUTOIMMUNITY; CASE CONTROL STUDY; CHROMOSOME TRANSLOCATION; CONTROLLED STUDY; DENMARK; FEMALE; GENE FREQUENCY; GENE INTERACTION; GENE REPLICATION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HOMOZYGOSITY; HUMAN; IMMUNOGENETICS; LARGE CELL LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MANTLE CELL LYMPHOMA; NONHODGKIN LYMPHOMA; POPULATION RESEARCH; PRIORITY JOURNAL; SWEDEN; T CELL LYMPHOMA; TUMOR GROWTH; ADOLESCENT; GENE TRANSLOCATION; GENETICS; MIDDLE AGED; ONCOGENE MYC; PROTO ONCOGENE; RISK; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; AGED; CASE-CONTROL STUDIES; CYCLIN D1; FEMALE; GENES, BCL-2; GENES, MYC; HUMANS; INTERLEUKIN-10; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; TRANSLOCATION, GENETIC; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 77955295002     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-010-9504-y     Document Type: Article

References (49)

1. Alexander DD, Mink PJ, Adami HO et al (2007) The non- Hodgkin lymphomas: a review of the epidemiologic literature. Int J Cancer 120(Suppl 12):1-39
2. Ekstrom-Smedby K (2006) Epidemiology and etiology of non- Hodgkin lymphoma-a review. Acta Oncol 45:258-271
3. Zhu K, Levine RS, Gu Y et al (1998) Non-Hodgkin's lymphoma and family history of malignant tumors in a case-control study (United States). Cancer Causes Control 9:77-82
4. Goldin LR, Pfeiffer RM, Gridley G et al (2004) Familial aggregation of Hodgkin lymphoma and related tumors. Cancer 100: 1902-1908
5. Skibola CF, Curry JD, Nieters A (2007) Genetic susceptibility to lymphoma. Haematologica 92:960-969
6. Skibola CF, Bracci PM, Halperin E et al (2008) Polymorphisms in the estrogen receptor 1 and vitamin C and matrix metalloproteinase gene families are associated with susceptibility to lymphoma. PLoS ONE 3:e2816
7. Rothman N, Skibola CF, Wang SS et al (2006) Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph Consortium. Lancet Oncol 7:27-38
8. Wang SS, Cozen W, Cerhan JR et al (2007) Immune mechanisms in non-Hodgkin lymphoma: joint effects of the TNF G308A and IL10 T3575A polymorphisms with non-Hodgkin lymphoma risk factors. Cancer Res 67:5042-5054
9. Bel Hadj Jrad B, Chatti A, Laatiri A et al (2007) Tumor necrosis factor promoter gene polymorphism associated with increased susceptibility to non-Hodgkin's lymphomas. Eur J Haematol 78:117-122
10. Purdue MP, Lan Q, Kricker A et al (2007) Polymorphisms in immune function genes and risk of non-Hodgkin lymphoma: findings from the New South Wales non-Hodgkin Lymphoma Study. Carcinogenesis 28:704-712
11. Wang SS, Cerhan JR, Hartge P et al (2006) Common genetic variants in proinflammatory and other immunoregulatory genes and risk for non-Hodgkin lymphoma. Cancer Res 66:9771-9780
12. Spink CF, Keen LJ, Mensah FK et al (2006) Association between non-Hodgkin lymphoma and haplotypes in the TNF region. Br J Haematol 133:293-300
13. Wang SS, Purdue MP, Cerhan JR et al (2009) Common gene variants in the tumor necrosis factor (TNF) and TNF receptor superfamilies and NF-kB transcription factors and non-Hodgkin lymphoma risk. PLoS ONE 4:e5360
14. Karin M, Greten FR (2005) NF-kappaB: linking inflammation and immunity to cancer development and progression. Nat Rev Immunol 5:749-759
15. Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A (2001) Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 19:683-765
16. Jaffe ES HN, Stein H, Vardiman JW editors (2001) WHO classification of tumours: pathology and genetics of tumours of hematopoietic and lymphoid tissues, Lyon, France. International Agency for Research on Cancer Press
17. Iqbal J, Sanger WG, Horsman DE et al (2004) BCL2 translocation defines a unique tumor subset within the germinal center B-cell-like diffuse large B-cell lymphoma. Am J Pathol 165:159-166
18. Huang JZ, Sanger WG, Greiner TC et al (2002) The t(14;18) defines a unique subset of diffuse large B-cell lymphoma with a germinal center B-cell gene expression profile. Blood 99:2285-2290
19. Kodet R, Mrhalova M, Krskova L et al (2003) Mantle cell lymphoma: improved diagnostics using a combined approach of immunohistochemistry and identification of t(11;14)(q13;q32) by polymerase chain reaction and fluorescence in situ hybridization. Virchows Arch 442:538-547
20. Kawasaki C, Ohshim K, Suzumiya J et al (2001) Rearrangements of bcl-1, bcl-2, bcl-6, and c-myc in diffuse large B-cell lymphomas. Leuk Lymphoma 42:1099-1106
21. Leder P, Battey J, Lenoir G et al (1983) Translocations among antibody genes in human cancer. Science 222:765-771
22. Wang SS, Cozen W, Severson RK et al (2006) Cyclin D1 splice variant and risk for non-Hodgkin lymphoma. Hum Genet 120:297-300
23. Zhang Y, Lan Q, Rothman N et al (2005) A putative exonic splicing polymorphism in the BCL6 gene and the risk of non- Hodgkin lymphoma. J Natl Cancer Inst 97:1616-1618
24. Morton LM, Purdue MP, Zheng T et al (2009) Risk of non- Hodgkin lymphoma associated with germline variation in genes that regulate the cell cycle, apoptosis, and lymphocyte development. Cancer Epidemiol Biomarkers Prev 18:1259-1270
25. Cleary ML, Galili N, Sklar J (1986) Detection of a second t(14;18) breakpoint cluster region in human follicular lymphomas. J Exp Med 164:315-320
26. Tsujimoto Y, Jaffe E, Cossman J et al (1985) Clustering of breakpoints on chromosome 11 in human B-cell neoplasms with the t(11;14) chromosome translocation. Nature 315:340-343
27. de Jong D (2005) Molecular pathogenesis of follicular lymphoma: a cross talk of genetic and immunologic factors. J Clin Oncol 23:6358-6363
28. Korsmeyer SJ (1992) Bcl-2 initiates a new category of oncogenes: regulators of cell death. Blood 80:879-886
29. Butler M, Corbally N, Dervan PA, Carney DN (1997) BCL-6 and other genomic alterations in non-Hodgkin's lymphoma (NHL). Br J Cancer 75:1641-1645
30. Vaux DL, Cory S, Adams JM (1988) Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 335:440-442
31. Dreyling MH, Bullinger L, Ott G et al (1997) Alterations of the cyclin D1/p16-pRB pathway in mantle cell lymphoma. Cancer Res 57:4608-4614
32. Smedby KE, Askling J, Mariette X, Baecklund E (2008) Autoimmune and inflammatory disorders and risk of malignant lymphomas- an update. J Intern Med 264:514-527
33. Baecklund E, Iliadou A, Askling J et al (2006) Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis. Arthritis Rheum 54:692-701
34. Smedby KE, Hjalgrim H, Melbye M et al (2005) Ultraviolet radiation exposure and risk of malignant lymphomas. J Natl Cancer Inst 97:199-209
35. D'Amore F, Christensen BE, Brincker H et al (1991) Clinicopathological features and prognostic factors in extranodal non- Hodgkin lymphomas. Danish LYFO Study Group. Eur J Cancer 27:1201-1208
36. Sorensen KM, Jespersgaard C, Vuust J et al (2007) Whole genome amplification on DNA from filter paper blood spot samples: an evaluation of selected systems. Genet Test 11:65-71
37. Milani L, Gupta M, Andersen M et al (2007) Allelic imbalance in gene expression as a guide to cis-acting regulatory single nucleotide polymorphisms in cancer cells. Nucleic Acids Res 35: e34
38. Howe D, Lynas C (2001) The cyclin D1 alternative transcripts [a] and [b] are expressed in normal and malignant lymphocytes and their relative levels are influenced by the polymorphism at codon 241. Haematologica 86:563-569
39. Wirtenberger M, Hemminki K, Forsti A et al (2005) c-MYC Asn11Ser is associated with increased risk for familial breast cancer. Int J Cancer 117:638-642
40. Jurinke C, van den Boom D, Cantor CR, Koster H (2002) Automated genotyping using the DNA MassArray technology. Methods Mol Biol 187:179-192
41. Phillips MS, Lawrence R, Sachidanandam R et al (2003) Chromosome- wide distribution of haplotype blocks and the role of recombination hot spots. Nat Genet 33:382-387
42. Emigh JF (1980) Pharmacy's glaucoma alert. Am Pharm NS20: 35-36
43. Smedby KE, Hjalgrim H, Askling J et al (2006) Autoimmune and chronic inflammatory disorders and risk of non-Hodgkin lymphoma by subtype. J Natl Cancer Inst 98:51-60
44. Clayton D, Chapman J, Cooper J (2004) Use of unphased multilocus genotype data in indirect association studies. Genet Epidemiol 27:415-428
45. Westfall PH, Zaykin DV, Young SS (2002) Multiple tests for genetic effects in association studies. Methods Mol Biol 184: 143-168
46. Wacholder S, Chanock S, Garcia-Closas M, El Ghormli L, Rothman N (2004) Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J Natl Cancer Inst 96:434-442
47. Skibola CF, Nieters A, Bracci PM et al (2008) A functional TNFRSF5 gene variant is associated with risk of lymphoma. Blood 111:4348-4354
48. Cerhan JR, Liu-Mares W, Fredericksen ZS et al (2008) Genetic variation in tumor necrosis factor and the nuclear factor-kappaB canonical pathway and risk of non-Hodgkin's lymphoma. Cancer Epidemiol Biomarkers Prev 17:3161-3169
49. Susova S, Trneny M, Soucek P (2006) Single nucleotide polymorphism in 50-flanking region of BCL6 is not associated with increased risk of non-Hodgkin's lymphoma. Cancer Lett 238: 142-145